نتایج جستجو برای: aβ1

تعداد نتایج: 893  

Journal: :JAMA neurology 2015
Yakeel T Quiroz Aaron P Schultz Kewei Chen Hillary D Protas Michael Brickhouse Adam S Fleisher Jessica B Langbaum Pradeep Thiyyagura Anne M Fagan Aarti R Shah Martha Muniz Joseph F Arboleda-Velasquez Claudia Munoz Gloria Garcia Natalia Acosta-Baena Margarita Giraldo Victoria Tirado Dora L Ramírez Pierre N Tariot Bradford C Dickerson Reisa A Sperling Francisco Lopera Eric M Reiman

IMPORTANCE Brain imaging and fluid biomarkers are characterized in children at risk for autosomal dominant Alzheimer disease (ADAD). OBJECTIVE To characterize and compare structural magnetic resonance imaging (MRI), resting-state and task-dependent functional MRI, and plasma amyloid-β (Aβ) measurements in presenilin 1 (PSEN1) E280A mutation-carrying and noncarrying children with ADAD. DESIG...

ژورنال: :مجله پزشکی ارومیه 0
ناصر خلجی nasre khalaji department of physiology, faculty of medicine, urmia university of medical sciences, nazlo road, urmia, iranارومیه، دانشگاه علوم پزشکی ارومیه، دانشکده پزشکی، گروه فیزیولوژی، تلفن: 32780803-044سازمان اصلی تایید شده: دانشگاه علوم پزشکی ارومیه (urmia university of medical sciences) جون سرکیسیان john sarkissian orbeli institute of neurophysiology, yerevan state university, yerevan, armeniaدانشگاه ملی ایروان، انستیتو نوروفیزیولوژی اوربیلیسازمان های دیگر: انستیتو نوروفیزیولوژی اوربیلی ورژینه چاوشیان vergine chavushyan orbeli institute of neurophysiology, yerevan state university, yerevan, armeniaدانشگاه ملی ایروان، انستیتو نوروفیزیولوژی اوربیلیسازمان های دیگر: انستیتو نوروفیزیولوژی اوربیلی واغیناک سرکیسیان vaghinak sarkissian orbeli institute of neurophysiology, yerevan state university, yerevan, armeniaدانشگاه ملی ایروان، انستیتو نوروفیزیولوژی اوربیلیسازمان های دیگر: انستیتو نوروفیزیولوژی اوربیلی

پیش زمینه و هدف: بیماری آلزایمر شایع ترین نوع جنون مغزی است که به آهستگی حافظه و مهارت های تفکری را از بین می برد. این بیماری درمان بخصوصی ندارد و سرانجام منجر به مرگ می شود. اخیراً پپتید غنی از پرولین از هیپوتالاموس (prp-1) استخراج شده که طیف وسیعی از عمل بیولوژیکی روی ایمنی و سیستم عصبی دارد. هدف از پژوهش حاضر بررسی اثر prp-1 روی فعالیت الکتریکی نورون های هیپوکامپ در بیماری آلزایمر ایجادشده تو...

Journal: :Journal of medicinal chemistry 2012
Laura C López Suzana Dos-Reis Alba Espargaró José A Carrodeguas Marie-Lise Maddelein Salvador Ventura Javier Sancho

Alzheimer's disease, characterized by deposits of amyloid β-peptide (Aβ), is the most common neurodegenerative disease, but it still lacks a specific treatment. We have discovered five chemically unrelated inhibitors of the in vitro aggregation of the Aβ17-40 peptide by screening two commercial chemical libraries. Four of them (1-4) exhibit relatively low MCCs toward HeLa cells (17-184 μM). The...

Journal: :PloS one 2015
Seulah Choi Donghoon Kim Tae-In Kam Seungpil Yun Sangjune Kim Hyejin Park Heehong Hwang Olga Pletnikova Juan C Troncoso Valina L Dawson Ted M Dawson Han Seok Ko

Glucocerebrosidase (GCase) functions as a lysosomal enzyme and its mutations are known to be related to many neurodegenerative diseases, including Gaucher's disease (GD), Parkinson's disease (PD), and Dementia with Lewy Bodies (DLB). However, there is little information about the role of GCase in the pathogenesis of Alzheimer's disease (AD). Here we demonstrate that GCase protein levels and enz...

Journal: :International Journal of Biological Macromolecules 2021

Alzheimer's disease is the most common form of senile dementia in world, and amyloid β peptide1-42 (Aβ1-42) one its two principal biological hallmarks. While interactome concept was getting forward scientific community, we proposed that study molecular interactions peptide with membranes will allow to highlight underlying mechanisms responsive AD. We have developed simple liposomal formulations...

2013
Youssef Zaim Wadghiri Jialin Li Jinhuan Wang Dung Minh Hoang Yanjie Sun Hong Xu Wai Tsui Yongsheng Li Allal Boutajangout Andrew Wang Mony de Leon Thomas Wisniewski

Amyloid plaques are a key pathological hallmark of Alzheimer's disease (AD). The detection of amyloid plaques in the brain is important for the diagnosis of AD, as well as for following potential amyloid targeting therapeutic interventions. Our group has developed several contrast agents to detect amyloid plaques in vivo using magnetic resonance microimaging (µMRI) in AD transgenic mice, where ...

2014
TE LIU YONGYI HUANG JIULIN CHEN HUIYING CHI ZHIHUA YU JIAN WANG CHUAN CHEN

Although large numbers of long noncoding RNAs (lncRNAs) expressed in the mammalian nervous system have been detected, their functions and mechanisms of regulation remain to be fully clarified. It has been reported that the lncRNA antisense transcript for β‑secretase‑1 (BACE1‑AS) is elevated in Alzheimer's disease (AD) and drives the rapid feed‑forward regulation of β‑secretase, suggesting that ...

2012
Andressa Bernardi Rudimar L Frozza André Meneghetti Juliana B Hoppe Ana Maria O Battastini Adriana R Pohlmann Sílvia S Guterres Christianne G Salbego

Neuroinflammation, characterized by the accumulation of activated microglia and reactive astrocytes, is believed to modulate the development and/or progression of Alzheimer's disease (AD). Epidemiological studies suggesting that nonsteroidal anti-inflammatory drugs decrease the risk of developing AD have encouraged further studies elucidating the role of inflammation in AD. Nanoparticles have b...

2016
Linnea Sandin Liza Bergkvist Sangeeta Nath Claudia Kielkopf Camilla Janefjord Linda Helmfors Henrik Zetterberg Kaj Blennow Hongyun Li Camilla Nilsberth Brett Garner Ann‐Christin Brorsson Katarina Kågedal

Genetic polymorphisms of immune genes that associate with higher risk to develop Alzheimer's disease (AD) have led to an increased research interest on the involvement of the immune system in AD pathogenesis. A link between amyloid pathology and immune gene expression was suggested in a genome-wide gene expression study of transgenic amyloid mouse models. In this study, the gene expression of l...

2017
Lu Zhang Yu Fang Xuan Cheng Ya-Jun Lian Hong-liang Xu Zhao-Shu Zeng Hong-can Zhu

BACKGROUND To validate our speculation that curcumin may ameliorate Alzheimer's disease (AD) pathogenesis by regulating PI(3,5)P2 and transient receptor potential mucolipin-1 (TRPML1) expression levels. METHODS We developed an animal model presenting AD by APP/PS1 transgenes. The mouse clonal hippocampal neuronal cell line HT-22 was treated with amyloid-β1-42 (Aβ1-42). Curcumin was administra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید